🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524638-24-00
Completed Phase I

CD5CAR-NK cells for refractory invasive mold disease

2025-524638-24-00 · tracked via the Priya Life Science EU tracker
Sponsor
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Sponsor type
Laboratory/Research/Testing facility
Therapeutic area
Bacterial Infections and Mycoses
Decision date
04/05/2026
Enrollment target
10
Sites
Spain

Condition studied

refractory invasive mold disease

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524638-24-00 on CTIS ↗ ← All trials in the EU